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Abstract
Background: The control of Clostridium difficile infection is a major international healthcare priority, hindered by a
limited understanding of transmission epidemiology for these bacteria. However, transmission studies of bacterial
pathogens are rapidly being transformed by the advent of next generation sequencing.
Results: Here we sequence whole C. difficile genomes from 486 cases arising over four years in Oxfordshire. We
show that we can estimate the times back to common ancestors of bacterial lineages with sufficient resolution to
distinguish whether direct transmission is plausible or not. Time depths were inferred using a within-host
evolutionary rate that we estimated at 1.4 mutations per genome per year based on serially isolated genomes. The
subset of plausible transmissions was found to be highly associated with pairs of patients sharing time and space
in hospital. Conversely, the large majority of pairs of genomes matched by conventional typing and isolated from
patients within a month of each other were too distantly related to be direct transmissions.
Conclusions: Our results confirm that nosocomial transmission between symptomatic C. difficile cases contributes
far less to current rates of infection than has been widely assumed, which clarifies the importance of future
research into other transmission routes, such as from asymptomatic carriers. With the costs of DNA sequencing
rapidly falling and its use becoming more and more widespread, genomics will revolutionize our understanding of
the transmission of bacterial pathogens.
Background
Clostridium difficile infection (CDI) has been a substan-
tial burden on healthcare facilities over the past decade
[1-3]. A widely held assumption that much transmission
occurs in hospitals between symptomatic patients was
reinforced when enhanced infection control introduced
in England in 2007 was followed by declines in the inci-
dence of CDI [3]. Identifying routes of nosocomial
transmission for lineages of C. difficile is an important
step towards further improvements of infection control.
Clinical isolates of C. difficile have been typed using a
wide variety of methods [4], but these schemes on their
own are not sufficiently discriminatory to investigate
propagation patterns on a fine scale. For example, a
highly pathogenic C. difficile lineage emerged clinically
10 years ago [5,6] and has until recently been responsi-
ble for up to 40% of C. difficile infections reported in
the United Kingdom [7,8]. Isolates from this lineage are
undistinguishable by conventional typing methods, since
they all correspond to a single PCR ribotype denoted
027 [3] and a single multi-locus sequence typing
(MLST) [9,10] type denoted ST1 [8,11].
In a previous study [12], we used comprehensive epi-
demiological information on patient admissions and
ward movements within the Oxfordshire hospitals [13]
to discriminate routes of nosocomial transmission
between symptomatic cases sharing the same MLST
type. This study found fewer cases of CDI than antici-
pated that could be attributed to acquisitions from other
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symptomatic patients sharing space and time on a hos-
pital ward [12]. One difficulty for the wider application
of this epidemiological approach is that the availability
of high-quality patient records is unusual. More typi-
cally, omissions or inaccuracies in such databases reduce
successful record linkage [13]. Furthermore, patient
pathways are only indirectly informative about transmis-
sion, in the sense that contact between patients does
not imply transmission, and conversely, transmission
can take place during unrecorded chance encounters in
hospital facilities or via third parties who were not suffi-
ciently ill to be sampled. We therefore sought a new
strategy for transmission analysis that does not require
epidemiological data. Instead, whole genomes were
sequenced to provide a genetic resolution that is directly
informative about fine scale patterns of transmission.
Comparisons of whole genome sequences have already
led to new insights into the epidemiology of other bacterial
pathogens such as Staphylococcus aureus [14] and Strepto-
coccus pneumoniae [15]. The sequencing of the first whole
genome of C. difficile revealed that it contains many
mobile genetic elements, which could contribute to its
pathogenicity and evolving antibiotic resistance [16]. A
comparison of a limited number of genomes (n = 30)
showed that the current diversity of C. difficile is the result
of a complex evolutionary history involving frequent hori-
zontal gene transfer and homologous recombination [17].
An important development in infectious disease research,
termed ‘phylodynamics’, aims to improve our understand-
ing of the relationships between the genetic variation of
pathogens and their epidemiology [18]. Although applic-
able in principle to all kinds of pathogens, the majority of
these studies to date have focused on viral infectious dis-
eases [19]. However, the development of next generation
sequencing technologies [20] has made the unification of
epidemiological and evolutionary approaches feasible for
bacterial pathogens as well.
For this study we sequenced, with high quality, gen-
omes from 486 CDI cases arising in Oxfordshire
between September 2006 and June 2010. These included
a third of the 1,460 cases reported during this period,
and those through to December 2009 have been pre-
viously studied by MLST [8]. The Oxford University
Hospitals (OUH) provide all acute services for the
region, and are therefore, a priori, considered the most
likely place of transmission. To test this hypothesis, we
reconstructed precise genealogies relating the C. difficile
isolates, and used these to assess the plausibility of
transmission between cases. We then compared the
results of our genomic analysis of plausible transmission
events with the proposed patient links that were deter-
mined from hospital admissions and ward movements
over the same period [12].
Results
Whole genome sequencing, quality control and
molecular clock
All genomes in this study were sequenced using Illu-
mina technology [21], with reference-based assemblies
performed using STAMPY [22] against the genome
sequence of strain 630 [16]. Additional variant calling
filters were applied to maximize the quality of the gen-
ome sequences generated (Materials and methods). We
performed the sequencing, assembly and calling of 66
samples between 2 and 8 times in order to assess
robustness, providing a total of 189 sequences (30 sam-
ples sequenced twice, 28 samples 3 times, 4 samples 5
times, and 1 sample 4, 6, 7 and 8 times). Across 224
comparisons, 222 pairs of sequences were identical, and
the remaining two pairs differed by only a single nucleo-
tide. Thus, we estimate that our error rate is of the
order of one mistake every 100 genomes sequenced. If
the probability of one error arising in a genome is
approximately 1%, and assuming that errors happen
independently (and the results above show no indication
that they do not), then the probability of two errors is
approximately 0.01%. This low error rate gives us confi-
dence that small numbers of pairwise differences
between genomes accurately reflect mutational
divergence.
In order to estimate the molecular clock, serial pairs of
isolates sampled from 91 CDI cases and sharing the same
ST, but separated by 1 to 561 days, were whole-genome
sequenced (Additional file 1). The within-host evolution-
ary rate of C. difficile was estimated at µ = 3.2 × 10-7
mutations per site per year, with a 95% credibility interval
ranging from 1.3 × 10-7 to 5.3 × 10-7. Our calculation
accounted for the instantaneous diversity of C. difficile
within a host, and this quantity was as observed in
experiments where several genomes were sequenced
from the same host and timepoint (Materials and meth-
ods). Our estimate of the short-term molecular clock rate
is two orders of magnitude larger than a previous long-
term molecular clock estimate [17]. Similar discrepancies
between short-term and long-term rates have been
reported in other pathogens - for example, in Campylo-
bacter jejuni [23] or Helicobacter pylori [24] - and could
be due to several evolutionary factors [25]. This result
highlights the importance of using a short-term molecu-
lar clock to date recent evolutionary events [24-26].
Our short-term molecular clock rate represents an
average of 1.4 mutations per genome per year (with a
95% credibility interval ranging from 0.6 to 2.3), and
values of the same order of magnitude have been
recently reported from whole genome comparisons of
various bacterial species [27], including Mycobacterium
tuberculosis [28], Vibrio cholerae [29], Escherichia coli
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[30] and Staphylococcus aureus [31]. Note that although
these bacterial rates of evolution per site are lower than
in viruses, the longer length of bacterial genomes means
that rates of genomic evolution are comparable. For
example, the hepatitis C virus, which has a genome of
9,600 bp, accumulates substitutions at a rate of 0.79 ×
10-3 per site per year [32], equivalent to 7.6 substitutions
per genome per year. This genomic rate is of the same
order of magnitude as the rate reported here for
C. difficile.
Concordance with MLST
Clustering of single genomes from each of the 486 CDI
cases (Additional file 2) by UPGMA (Figure 1a) con-
firmed the correspondence of major phylogenetic
lineages to STs. Three exceptions, ST89, ST57 and
ST67, fell within the diversity of ST6, ST12 and ST41,
respectively. Such inclusions can be easily explained; for
example, for ST89 by clonal expansion of a genetically
differentiated descendant of the ST6 lineage. Provided
that MLST data are not wrongly interpreted as implying
the monophyly of each ST, such exceptions do not
represent inconsistencies between MLST and whole-
genome phylogeny. A previously described example is
the inclusion in Neisseria meningitidis of ST66 within
the diversity of ST8 [33].
The extent of genomic diversity within lineages was
highly variable (indicated by the height of the triangles
in Figure 1a) between STs. In these data, ST44 presents the
two most divergent genomes that share the same sequence
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Figure 1 Global and group-by-group phylogenetic analysis of the genomes. (a) Phylogeny of all 486 genomes from included CDI cases.
Clades corresponding to STs are shown as triangles, the height of which represents the diversity of each ST. Numbers in parentheses indicate
the number of genomes belonging to each ST sequenced. The 15 STs or groups of closely related STs analyzed in detail are shaded, and
indexed from 1 to 15. (b) Detailed phylogeny for samples in group 9. The ten genomes of ST54 are labeled from A to J and the five genomes
of ST63 are labeled from K to O. The × co-ordinate of each genome indicates time of isolation. For each internal node of the tree
(corresponding to a common ancestor), the mean inferred age is shown on the tree with the 95% credibility interval around this mean shown
as a blue bar.
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type, with one pair differing at 4,273 sites. The minimum
number of differences between two genomes belonging to
separate STs (excluding the nested STs above) was 771,
representing over a hundred years of evolution. Grouping
by MLST is therefore consistent with the phylogenetic
structure evident from whole genome data, but finer reso-
lution is necessary to study epidemiological events.
Extent of recombination
In the light of strong evidence for extensive homologous
recombination in C. difficile [8,17,34], the microevolution-
ary history of 15 clades represented in our data (Figure 1a)
was reconstructed independently using ClonalFrame [35].
Estimates of the relative effects of mutation and recombi-
nation (r/m) [34,36] varied by two orders of magnitude
between lineages (Table 1), with values above 5 in groups
1, 11 and 14 and values below 0.05 in groups 3 and 4. The
relative effect of recombination has previously been esti-
mated to be between 0.1 and 0.4 in C. difficile based on
MLST data [34,36], but recombination is likely to play a
lesser role on the highly conserved MLST loci than it does
throughout the genome [8,36]. A comparison of whole
genomes covering the complete diversity of C. difficile
yielded an estimate between 0.63 and 1.13 [8,34], which
falls roughly at the middle of the interval of values esti-
mated on a group-by-group basis (Table 1).
Our results show that the effect of recombination varies
substantially between lineages of C. difficile. Evidence for
non-constant effects of recombination have been reported
previously in other pathogenic species such as Moraxella
catarrhalis [37], Listeria monocytogenes [38] and Escheri-
chia coli [39]. These variations are often found associated
with a change in ecology or pathogenicity [36]. ST1, the
hypervirulent strain associated with major hospital out-
breaks and severity over the last decade [5,6], displayed
very little evidence for recombination, and therefore may
be best described as a monomorphic pathogenic clone
[40]. Interestingly, ST37 (PCR-ribotype 017), the only
toxin A-B+ strain in this study [8], shared this feature.
Epidemiological interpretation of genealogies
The microevolutionary history for group 9 chosen to
illustrate epidemiological interpretation is shown in Fig-
ure 1b (equivalent genealogies for the other 14 groups
are shown in Additional file 3). Once the recombination
events inferred by ClonalFrame are accounted for, time-
scaling is informed by the molecular clock estimate µ
and the known dates of isolation of each genome.
Patients K to O represent all five cases of ST63 arising
during the 3.5 year study period, which actually
occurred over an interval of 9 weeks. Although one of
these samples was obtained by a family doctor in pri-
mary care and the others were taken in the three sepa-
rate OUH hospitals, K, L, and M had actually shared
time on one ward, while N and O shared time on
another. Our independent genomic analyses revealed
that the estimated date of the common ancestor of K, L
and M could be as little as a few days before samples
were taken (these three genomes have no observed dif-
ferences), consistent with transmission on the ward
between these three patients. Thus, epidemiology con-
firms the genetic signal of possible nosocomial transmis-
sion. Likewise, we cannot exclude the possibility of
direct transmission between N and O, given that the
time back to their most recent common ancestor
(TMRCA) may be as short as five months. However,
Table 1 Properties of the 15 groups highlighted in Figure 1a
Group STs Counts min(d)a max(d)a mean(d)a Mutb Recc Subd r/me
1 11 31 0 285 46 166 61 865 5.22
2 5,22 9,5 0 1,202 614 364 49 1,364 3.75
3 37 18 0 49 22 100 1 3 0.03
4 1 81 0 24 6 79 1 3 0.04
5 17 19 0 114 42 161 18 191 1.19
6 10 37 0 120 30 273 22 155 0.57
7 44 52 0 4,273 911 2,226 135 4,134 1.86
8 35 8 0 1,026 307 621 9 661 1.07
9 54,63 10,5 0 6,009 2,633 2,238 180 5,678 2.54
10 58 16 0 3,130 1,306 880 149 3,845 4.37
11 12,57 8,2 0 2,953 1,368 426 78 3,189 7.49
12 3 7 2 468 225 386 21 454 1.18
13 6,89 62,1 0 344 84 1,197 255 1,784 1.49
14 2,13,49,14 18,2,8,7 0 3,913 1,675 913 201 6,495 7.11
15 42 45 0 155 24 206 22 178 0.87
ad is the pairwise distance between two genomes from different CDI cases. bEstimated number of mutation events. cEstimated number of recombination events.
dEstimated number of substitutions introduced by recombination. eRatio of the effects of recombination versus mutation.
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any direct transmission between K, L, and M on the one
hand, and N and O on the other, can be ruled out on
the basis that their TMRCA is at least ten years before
the first isolation. All five patients had received treat-
ment from clinicians in the same speciality, raising con-
cerns that they were spreading CDI between hospitals,
but our whole genome sequencing provides strong evi-
dence against this hypothesis. During the study period
there were nine isolations of ST54, within which three
pairs of genomes were closely related (D and E, I and J,
F and G). Only D and E shared time on the same ward.
I and J were on adjacent wards at the same time,
whereas F and G were never in the same OUH hospital at
the same time nor in the same part of the ward or even
hospital area at different times, suggesting either transmis-
sion outside of the OUH, or the involvement of a third
party (either an asymptomatic carrier or a false-negative
tested patient). Strains isolated from four other patients
(A, B, C and H) had no close relatives (Figure 1b).
Assessing the plausibility of direct transmission between
two cases
In order to interpret the dated genealogies reconstructed
by ClonalFrame (Figure 1b; Additional file 3) for all 486
cases, let us consider what happens when transmission
occurs between two patients (Figure 2). It is important
to notice that the strains isolated and sequenced from
each of the two patients (represented by red dots in
Figure 2) only represent single members of the bacterial
populations colonizing these hosts. Nevertheless, the
TMRCA of the two sampled genomes (represented by a
blue dot in Figure 2) can be estimated and necessarily
predates the transmission event [41]. Let the incubation
period be defined as the time separating the infection
(red arrow) from the symptomatic phase during which a
sample is taken (red dot). For nosocomial CDI this is
estimated to be days to weeks rather than months [42].
The directionality of a putative transmission event is not
generally known, but it is clear from Figure 2 that if
transmission occurred in one or other direction, the
TMRCA is at most two incubation periods prior to
either sample being taken.
The principle described above was applied to all pairs
of CDI cases (Figure 3). Putative transmission links
within pairs were ruled out if their TMRCA was more
than six months. Conversely, if the TMRCA of a pair
could be less than six months, transmission between the
patients was inferred to be a possibility but not a cer-
tainty. The choice of this cut-off at six months is arbi-
trarily chosen to be conservative in the proportion of
direct transmissions ruled out. We note that halving it
or doubling it does not result in many changes in inter-
pretation (Figure 4).
Results of the transmission analysis
We considered all pairs of genomes having the same ST
and isolated within a month of each other, so that with-
out whole genome sequencing, transmission would seem
likely. With the exception of ST1, only 19% (67/358) of
pairs could share a common ancestor within six months
(Additional file 4). This proportion was much higher in
ST1 (63%, 167/267), consistent with the epidemic nature
of this C. difficile lineage [5,6]. ST6, in contrast to ST1,
showed a very low proportion of pairs for which direct
transmission was possible (5%, 5/103). In spite of being
a frequent cause of CDI, the epidemiological behaviour
Patient A
Patient B 
Time 
Figure 2 Conceptual representation of how the TMRCA relates to transmission. Two patients A and B are shown, and a transmission event
happened from A to B as indicated by a red arrow. Within each patient, a colonizing population evolves between the time of infection and the
time when the patient becomes symptomatic, at which point a single strain is isolated, represented by a red dot. The most recent common
ancestor of the two isolates from A and B is shown as a blue dot.
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of ST6 must differ from that associated with ST1. Simi-
lar results were obtained when considering all pairs of
genomes isolated within three months of each other
(Additional file 4).
The analysis above assumed that evolution takes
place at the constant molecular rate µ estimated within
patients. However, C. difficile forms resistant spores
that can survive either within a patient or in the envir-
onment for months or even years [2], during which
evolution is effectively suspended. Taking this effect
into account in a phylogenetic framework would be
difficult, but evolutionary interruptions would result in
underestimates of the true times to common ancestors,
assuming a constant molecular clock. Pairs of cases for
which we ruled out transmission would therefore
remain unlinked.
Validation with epidemiological data
In a previous study, we used information on patient ward
movements in the OUH to identify which CDI cases had
shared hospital time and space [12]. This group of hospi-
tals provide all acute care, and >90% of specialist services
within the region. These data were not restricted to the
time and place of the sample tested for CDI, to allow for
transmission during incubation and pre-symptomatic
infection phases. Patients with the same ST that were
found to be epidemiologically linked are represented using
the same colors on each horizontal panel of Figure 3. Of
the 234 pairs of same-ST CDI cases occurring within a
month of each other and with a recent (<6 months) com-
mon ancestor, 130 (56%) had previously shared time
and space in hospital, compared to only 9% (36/391) of
the pairs with less recent common ancestors (Figure 4).
2007 2008 2009 2010
15
14
13
12
11
10
C F G H E D
B I J
O N
L MK
A9
8
7
6
5
4
3
2
1
Figure 3 Summary of results of the transmission analysis. Each horizontal panel corresponds to one of the 15 groups defined in Figure 1a.
Each circle represents a CDI case, and is located on the x-axis according to the isolation date. Cases are linked by horizontal lines where the
genomic analysis found that transmission was possible. The 15 genomes in group 9 are labeled from A to O as in Figure 1b. Within each group,
cases that are connected with one another based on the epidemiological analysis are indicated by circles of the same unique color, and cases
with no identified epidemiological connections are shown in gray. The same colors are used to label isolates in Additional file 3.
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This association between the genomic and epidemiological
analyses is strong and significant (Kappa = 0.49, P < 10-5;
Additional file 5), providing external validation for both.
However, 25% of same-ST pairs from patients sharing
time and space on wards had TMRCAs of more than
6 months (Figure 4), thus ruling out direct patient to
patient transmission. Again, ST1 stands out compared
to other groups, with a higher proportion of epidemiolo-
gically unlinked pairs having close genealogical relation-
ships of less than six months (Figure 4). We do not
infer that all these pairs represent direct transmissions,
because showing this would require the ability to rule in
when transmission happened whereas this study focused
on ruling out when it did not. Nevertheless, ST1 illus-
trates the ongoing challenges posed by epidemic out-
breaks for identifying transmission pathways, even when
genomic and epidemiological data are combined.
Discussion
This study has identified likely instances of direct transmis-
sion that link a subset of 486 cases of CDI arising in
Oxfordshire over 4 years. To do so, we first estimated the
molecular clock rate of C. difficile from genomes sampled
serially from within patients, and then applied this rate to
reconstruct time-scaled genealogies that can be interpreted
epidemiologically. This general phylodynamic approach
has been previously applied in several recent viral studies
[43-45], but here we used ClonalFrame [35] rather than
BEAST [46]. Both algorithms are built on the same con-
cepts of Bayesian phylogenetics [47,48], the main difference
being that ClonalFrame accounts for the recombination
events, which can disrupt a phylogenetic reconstruction if
ignored [49]. Inclusion of variable sites introduced by
recombination with those introduced by mutation would
result in overestimation of the dates of common ancestors.
However, having identified the recombination events, the
ClonalFrame algorithm permits TMRCA estimations based
on the mutation events only. In line with previous studies
[8,17,34], our results indicate levels of recombination in
C. difficile that are too high to be ignored and justify our
approach.
Since our estimated molecular clock is based on short-
term data, it may not be suited to date ancient events
[24-26]. We therefore interpret with caution the dating
of ancient nodes of our phylogenetic trees - for example,
the estimated age for the common ancestor of all ST44
of between 400 and 800 years ago (Additional file 3).
However, this short-term molecular clock is well suited
to estimate the dates of recent events, and in particular
to determine whether a pair may have had a common
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Figure 4 Distributions of the TMRCA for all pairs of genomes with the same ST and isolated within a month of each other. Top left:
48 pairs not from ST1 and with an epidemiological link based on shared time and space on a ward. Bottom left: 118 pairs not from ST1 and
without an epidemiological link. Top right: 310 pairs from ST1 and with an epidemiological link. Bottom right: 149 pairs from ST1 and without an
epidemiological link.
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ancestor less than six months ago as required for our epi-
demiological interpretation.
Only whole-genome sequencing could provide the fine
resolution of microevolutionary reconstruction necessary
to investigate transmission against a nosocomial back-
ground in our study. However, limitations to the conclu-
sions we can draw arise from our sampling design. In
particular, we can comment neither on the diversity of the
colonizing population within patients nor on the fre-
quency of mixed infections [50], but we can clarify our
probabilistic genealogical approach with respect to these
concerns. Within-patient diversity is illustrated in Figure 2
where transmission from patient A to patient B is shown.
For each patient, there is clonal expansion of the coloniz-
ing founder following initial infection (represented by dif-
ferent genealogies within each host). We estimate the time
back to the most recent common ancestor (represented by
the blue dot) of single isolates sampled from each patient
(represented by the two red dots). Irrespective of other
diversity in the populations that have colonized patients A
and B, the date of this most recent common ancestor
(blue dot) has to be after the time of infection of A (first
red arrow) and before transmission leads to infection of B
(second red arrow). The model of transmission shown in
Figure 2 makes the simplifying assumption that a single
genome is the founder of each new infection. In reality,
each infection may be started by a number of cells or
spores, which represents a subsample of the genomic
diversity of the donor. However, our estimates of the
instantaneous within-host diversity p in C. difficile from
both longitudinal and synchronous data (Materials and
methods; Additional file 6) indicate that this quantity is
small, justifying the use of our model.
We have been able to rule out direct transmission for
the majority of pairs of patients where it would have
seemed likely based on conventional typing methods. For
these pairs, our results suggest there must have been a
number of intermediates in the transmission chains - or
considerably longer incubation periods than have been
previously estimated, which seems unlikely for most symp-
tomatic inpatients. Some of these intermediates may be
found amongst the reported CDI cases that were not
included in our study (486 were sequenced out of 1,460).
However, the deep TMRCAs between many of the CDI
cases (Figure 4) would require many more intermediates
than could be accounted for by the CDI cases not included
for genomic sequencing.
The effectiveness of the increased infection control mea-
sures initiated in England in 2007 is compatible with the
current evidence that transmission between symptomatic
hospital inpatients accounts for only a minority proportion
of nosocomial CDI acquisitions. The deep TMRCAs
between the genomes sampled from many of the epide-
miologically linked CDI cases are in line with a growing
awareness of community-associated CDI, where conven-
tional risk factors for disease are frequently absent [2,51].
Results presented here therefore highlight the need for
future studies to explore transmission routes other than
those due to symptomatic inpatient CDI cases. Asympto-
matic colonization, albeit potentially transient, may have
become an important source of C. difficile [52], as indi-
cated by high levels of the general population having
serum and colonic antibodies to C. difficile toxins [53,54].
Perhaps more importantly, the participation of asympto-
matic carriers in chains of transmission could explain the
deep TMRCAs found for many pairs of cases (Figure 4).
Whilst up to approximately 10% of hospital inpatients
have been identified as colonized in prospective studies
[55], given the large inpatient pool, asymptomatic coloni-
zation could form a substantial reservoir for CDI. Further-
more, the estimates available for C. difficile colonization
are dependent on bacterial culture, which may underesti-
mate true bacterial prevalence. Current strategies focused
on symptomatic patients for reducing nosocomial trans-
mission [56] may therefore have only limited effectiveness,
especially as epidemic strains are successfully contained.
Conclusions
This study demonstrates the utility of microevolutionary
analysis based on whole-genome sequencing for studying
C. difficile transmission. With genomics having an
increasing role in the rapid identification of outbreaks, it
is clear that microevolutionary analysis of such data will
be important to improve clinical management of this
endemic healthcare-associated infection. Our methodol-
ogy applied to future genomic analyses could produce
evidence of transmission events as preliminary justifica-
tion for more detailed epidemiological investigation sur-
rounding particular CDI cases. Analogous genomic
studies are likely to illuminate the transmission behaviour
and underlying epidemiology of other bacterial pathogens
where similarly high rates of genomic microevolution
have been found [28-31]. For C. difficile, as for many bac-
terial pathogens, the advent of rapid and affordable
sequencing technology [20], and in particular novel rapid
benchtop sequencing methods [57], should radically alter
our capacity for understanding transmission biology at
individual, local and national levels.
Materials and methods
Sample collection
A collection of 1,290 clinical isolates of C. difficile sub-
mitted for testing at the Oxford University Hospitals
(Oxford, UK) between September 2006 and December
2009 was previously described [8] and typed using a
MLST scheme [11]. This collection has since been
extended to include the period from January 2010 to June
2010. It consists of all enzyme immunoassay positive,
Didelot et al. Genome Biology 2012, 13:R118
http://genomebiology.com/2013/13/12/R118
Page 8 of 13
culture positive isolates from samples submitted to the
OUH microbiology laboratory, including from admitted
inpatients at other smaller Oxfordshire hospitals (mental
health, orthopaedic and community hospitals) and primary
care facilities. This laboratory conducts all C. difficile test-
ing for Oxfordshire. A subset of this extended collection
was studied here: (i) samples from 486 CDI cases (unique
patient/ST combination) in 462 different patients, repre-
senting 33% of the 1,460 CDI cases during the study per-
iod (Additional file 2); (ii) consecutive samples with the
same ST isolated from 91 of these CDI cases with time
intervals ranging from 1 to 561 days (Additional file 1).
Samples for (i) were chosen to represent the breadth of
diversity within common disease-causing strains circulat-
ing around the OUH at this time (by sequencing at least
one sample of all STs with >12 cases in the study period),
enhanced for potential transmission events by sequencing
as many samples as possible for four wards with ongoing
outbreaks as defined by UK Department of Health gui-
dance (three or more cases on a ward in one week) and
from STs where a high proportion of cases shared space
and time on a ward. As a consequence, 366 (75%) of CDI
cases were inpatients (admitted overnight) at the time of
sampling, a slightly higher proportion than unsequenced
cases (65%, P = 0.005). However, 277 (57%) of CDI cases
were female and the median age at diagnosis was 79
(interquartile range 67 to 86) years, very similar to unse-
quenced cases (P > 0.6).
Sample treatment
Stools identified as enzyme immunoassay positive with
sufficient sample remaining underwent selective culture.
Industrial methylated spirits (0.5 ml) was added to a
0.5 ml fecal sample (pea-sized portion if the stool was
formed), and the sample was vortex mixed and incubated
at room temperature for 1 h. A loopful was then cultured
onto modified Brazier’s cycloserine-cefoxitin-egg yolk
(CCEY) agar (CCEY agar base containing cycloserine-
cefoxitin supplement and 5% defibrinated horse blood),
and the plates were incubated anaerobically at 37°C for up
to 7 days. A single colony was subcultured onto a Colum-
bia blood agar (CBA) plate and incubated for 48 h, after
which colonies giving the characteristic odour and fluores-
cence under UV illumination were obtained and under-
went MLST [11]. For long-term storage, isolates were
emulsified in nutrient broth containing 10% glycerol and
stored at -80°C.
DNA preparation
Each previously frozen isolate was inoculated on to a CBA
plate and incubated anaerobically for 48 hours at 37°C. A
number of colonies were sampled from the resulting
growth to be representative of the frozen stock culture,
and transferred to a new CBA plate and incubated
anaerobically for a further 48 hours at 37°C. DNA was
extracted using a commercial kit (FastDNA, MP Biomedi-
cals, Santa Ana, CA, USA; or QIAamp, Qiagen, Hilden,
Germany).
Library preparation and sequencing
DNA was sequenced at the Wellcome Trust Centre for
Human Genetics (WTCHG), Oxford, UK, using the Illu-
mina, Inc. (San Diego, CA, USA) sequencing-by-synthesis
technology [21,58]. A combination of standard Illumina
and in-house protocols were used to produce multi-
plexed paired-end libraries with an average insert size of
approximately 200 bp. Twelve-plex pooled libraries were
sequenced on the Genome Analyzer II (GAII) or GAIIx
platforms to produce 51 or 100-108 bp reads, respec-
tively, and 96-plex pooled libraries were sequenced on
the HiSeq2000 platform to produce 99 or 100 bp paired
reads. In some cases, the same pooled libraries were
sequenced in two or more lanes or in different runs, then
combined to produce a single set of reads for analysis.
Assembly and variant calling
The full set of properly paired reads from each isolate was
mapped to a reference genome using Stampy [22] v1.0.11
without Burrows-Wheeler Alignment [59] pre-mapping,
using an expected divergence (substitution rate) of 0.01 and
with default values for other program options, to produce
BAM files used in subsequent base-calling. All isolates
were mapped against the single bacterial chromosome of
C. difficile strain CD630 [16] (GenBank AM180355.1, GI
115249003, length of 4,290,252 bp). The median depth of
coverage (number of reads mapped to reference positions)
across all genomes was 39× with an interquartile interval
ranging from 28× to 67×. We called single nucleotide var-
iants using the SAMtools [60] ‘mpileup’ command and
with options ‘-M0 -Q30 -q30 -o40 -e20 -h100 -m2 -D -S’.
We only used the single nucleotide variants that met the
following criteria: (1) at least 5 reads with at least 1 read in
each direction; (2) no other variant within 12 bases; (3)
depth of high-quality coverage between the 2.5 and 97.5
percentiles of all sites for that isolate; (4) sites in unique
regions of the reference genome, as judged by constructing
a mask of all regions with self similarity using BLAST [61];
(5) at least 75% of reads support the call; and (6) a call must
be homozygous under a diploid model. This resulted in
calls for mean 85% of the positions of the CD630 reference
genome.
Molecular clock estimate from longitudinal data
For the 91 pairs of genomes sequentially isolated from the
same patient and described above, we counted the number
A of sites called in both genomes, and the number B of
these that were called differently (Additional file 1). In line
with Figure 2, we need to estimate the mutation rate
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within a lineage while allowing for the possibility that vari-
able sites may also represent within-host evolution prior
to the initial date of sampling. Accordingly, we assumed a
model for the data in which B is Poisson distributed with
compound parameter p*A+µ*T*A, where p is the instanta-
neous within-host diversity, µ is the molecular clock rate
and T is the time separating the two genomes [24,62]. To
estimate the two unknown parameters µ and p in this
model, Bayesian inference was performed using the unin-
formative prior uniform over (0,∞)). The point estimate
for the molecular clock rate µ was 3.2 × 10-7 mutations
per site per year, with a 95% credibility interval ranging
from 1.3 × 10-7 to 5.3 × 10-7. The instantaneous within-
host diversity p had a point estimate of 5.7 × 10-8 differ-
ences per site, with a 95% credibility interval ranging from
1.5 × 10-8 to 11.1 × 10-8. This value of p is equivalent to
an expected number of differences across the genome in
the interval range of 0.06 to 0.48. To check that this esti-
mate is realistic, we fully sequenced the genomes for
between 9 and 12 different C. difficile colonies grown
from individual clinical samples in 7 different experiments
(Additional file 6). We found that the diversity between
these genomes was between p = 0 and p = 0.47. These
results are highly consistent with our estimate above of
the instantaneous within-host diversity of C. difficile from
longitudinal data.
Comparative analysis of genomes from distinct cases
A global phylogenetic tree was computed using UPGMA
[63] on a single genome from each of the 486 CDI cases
(Figure 1a). Fifteen groups of closely related genomes
were analyzed further as highlighted in Figure 1a.
UPGMA is a crude method to compute a phylogeny, but
here it was only used to investigate the relationships
between STs and to define groups of related genomes
within which more precise phylogenetic inference was
performed using ClonalFrame [35] (see below). Clonal-
Frame could not be applied directly to the whole set of
486 genomes because of its high computational cost
when applied to many highly diverse genomes. Further-
more, applying ClonalFrame separately to each group
allowed us to uncover important evolutionary differences
between them.
ClonalFrame [35] version 1.2 was applied to each group
separately in order to infer a within-group genealogy
accounting for the possible occurrence of homologous
recombination. The ClonalFrame model incorporates
both mutation and recombination, and is able to disen-
tangle the effects of these two processes on the genetic
data. The signal indicating recombination imports are
nucleotide differences that are clustered within a geno-
mic interval. Other available software packages for phylo-
genetic reconstruction do not account for recombination
and in this situation could therefore over-estimate branch
lengths. The Monte-Carlo Markov Chain [64] (MCMC)
within ClonalFrame was run on each group for 20,000
iterations, with the first half discarded as burn-in. Repeat
runs with different initial values were performed and
compared to confirm convergence and mixing of the
MCMC. Since ClonalFrame identifies which substitutions
were introduced by mutation (rather than recombina-
tion), these can be used in combination with the muta-
tion rate µ estimated from longitudinal data (with the
uncertainty being carried through) and the known times
of isolation of the genomes in order to infer the mean
and 95% credibility intervals of the ages of the common
ancestors [32,46,65]. Estimating times back to common
ancestors in a phylogenetic context allows for more accu-
rate dating than if sequences were considered in a pair-
wise fashion, because the age of the common ancestor of
a pair is informed not only by the number of differences
between this pair but also by their relationship with all
other sequences.
The mean age of ancestral nodes are shown by the
position on the x-axis in Figure 1b and Figure 0A ddi-
tional file 3, and the credibility intervals are shown by the
blue bars around them. These figures were drawn using
FigTree version 1.3.1 [66]. They represent majority-rule
consensus trees based on posterior samples of phyloge-
nies [67]. To assess the plausibility of direct transmission
between two cases, the lower bound of the 95% credibil-
ity interval around the age of their most recent common
ancestor node was used. If the node corresponding to the
most recent common ancestor was unresolved in the
majority-rule consensus tree, the phylogeny most likely
to be compatible with transmission (that is, with the two
branches supporting the two cases most closely related)
was used in order to be conservative in ruling-out
transmission.
Epidemiological links between patients
In order to validate our genomic analysis of transmission,
we compared it with the results of a previous epidemiolo-
gical study on the same patients [12]. Epidemiological
links were made when two CDI cases shared a ST and
time on a ward, either (i) after the sample of first case
(the ‘donor’) and before the sample of the second case
(the ‘recipient’) or (ii) before both samples were taken.
For each link, the ‘minimum infectious period’ necessary
for transmission to have occurred was defined as the
time between the first sample from the potential donor
and ward contact with the recipient. The ‘incubation per-
iod’ was defined as the time between this ward contact
and the first sample in the recipient. Incubation periods
were assumed to be no greater than 12 weeks, and infec-
tious periods no greater than 8 weeks. The subset of 486
CDI cases studied here with whole genome sequencing
were considered epidemiologically linked if they were
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part of a potential transmission network defined by these
links; that is, were counted as epidemiologically linked
even if there were intermediate linked CDI cases not
whole genome sequenced.
Data availability
The genomic data have been deposited in the NCBI Short
Read Archive under accession number ‘ERP001520’ and
can be accessed online [68].
Additional material
Additional file 1: Table summarizing the longitudinal data. Each row
corresponds to one of the 91 patients for which two samples were taken
on different dates, and the columns indicate when the two samples
were taken and how they differed.
Additional file 2: Table summarizing the transmission data. Each row
corresponds to one of the 486 CDI cases described in the main text.
Additional file 3: Figure showing the microevolutionary analysis for
all 15 groups. Equivalent plot to Figure 1b for the 15 groups
highlighted in Figure 1a.
Additional file 4: Table comparing the effect of considering pairs
within one or three months of each other. Proportion of pairs of
cases for which the TMRCA could be less than six months ago, when
considering pairs of cases from the same ST and separated by a
maximum of one month (left) or three months (right).
Additional file 5: Figure assessing the strength of agreement of the
epidemiological and genomic analyses of transmission. The arrow at
Kappa = 0.49 indicates Cohen’s Kappa coefficient of agreement between
links produced by the genomic (TMRCA <6 months) and epidemiological
(shared time and space on hospital wards) analysis. The histogram shows
the density of Kappa arising by chance, estimated using 10,000 random
permutations of the epidemiological labels within each ST.
Additional file 6: Table summarizing the results of instantaneous
within-host genomic diversity. Each row corresponds to one of seven
experiments where 9 to 12 genomes were sequenced from multiple
colonies grown from a single clinical sample. The genetic relationships
between the genomes is described, and the average pairwise distance
between genomes p is reported in the last column.
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